Article
Erdheim-Chester disease.
Rheumatic diseases clinics of North America - 1 May 2013
Haroche Julien, Arnaud Laurent, Cohen-Aubart Fleur, Hervier Baptiste, Charlotte Frédéric, Emile Jean-François, Amoura Zahir
Abstract excerpt
Erdheim-Chester disease (ECD) is a rare form of non-Langerhans' cell histiocytosis. Diagnosis of ECD is based on the identification in tissue biopsy of histiocytes, which are typically foamy and immunostain for CD68+ CD1a-. Central nervous system involvement is a major prognostic factor in ECD. Interferon alpha may be the best first-line therapy and significantly improves survival of ECD. The BRAFV600E mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
